Закон Пермского края от 04.12.2015 № 572-ПК

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦радикальная влагалищная       ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦трахелэктомия с               ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦видеоэндоскопической тазовой  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденэктомией              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦расширенная экстирпация матки ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦с парааортальной              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденэктомией, резекцией   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦смежных органов               ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦нервосберегающая расширенная  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦экстирпация матки с           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦придатками и тазовой          ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденэктомией              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦нервосберегающая расширенная  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦экстирпация матки с           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦транспозицией яичников и      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦тазовой лимфаденэктомией      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦расширенная экстирпация матки ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦с придатками или с            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦транспозицией яичников после  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦предоперационной лучевой      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦терапии                       ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C54       ¦злокачественные        ¦хирургическое  ¦расширенная экстирпация матки ¦          ¦

¦     ¦                      ¦                  ¦новообразования тела   ¦лечение        ¦с парааортальной              ¦          ¦

¦     ¦                      ¦                  ¦матки                  ¦               ¦лимфаденэктомией и            ¦          ¦

¦     ¦                      ¦                  ¦(местнораспространенные¦               ¦субтотальной резекцией        ¦          ¦

¦     ¦                      ¦                  ¦формы).                ¦               ¦большого сальника             ¦          ¦

¦     ¦                      ¦                  ¦Злокачественные        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦новообразования        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦эндометрия I A-III     ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦стадии с осложненным   ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦соматическим статусом  ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦(тяжелая степень       ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦ожирения, тяжелая      ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦степень сахарного      ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦диабета и т.д.)        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦нервосберегающая экстирпация  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦матки с придатками, с верхней ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦третью влагалища и тазовой    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденкэтомией              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦экстирпация матки с           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦транспозицией яичников и      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦тазовой лимфаденэктомией      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦экстирпация матки с           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦придатками, верхней третью    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦влагалища, тазовой            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденэктомией и            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦интраоперационной лучевой     ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦терапией                      ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C56       ¦злокачественные        ¦хирургическое  ¦экстирпация матки с           ¦          ¦

¦     ¦                      ¦                  ¦новообразования        ¦лечение        ¦придатками, субтотальная      ¦          ¦

¦     ¦                      ¦                  ¦яичников I-IV стадии.  ¦               ¦резекция большого сальника с  ¦          ¦

¦     ¦                      ¦                  ¦Рецидивы               ¦               ¦интраоперационной             ¦          ¦

¦     ¦                      ¦                  ¦злокачественных        ¦               ¦флюоресцентной диагностикой и ¦          ¦

¦     ¦                      ¦                  ¦новообразований        ¦               ¦фотодинамической терапией     ¦          ¦

¦     ¦                      ¦                  ¦яичников               ¦               ¦                              ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦  C53, C54, C56,  ¦рецидивы               ¦хирургическое  ¦тазовые эвисцерации           ¦          ¦

¦     ¦                      ¦       C57.8      ¦злокачественных        ¦лечение        ¦                              ¦          ¦

¦     ¦                      ¦                  ¦новообразований тела   ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦матки, шейки матки и   ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦яичников               ¦               ¦                              ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C60       ¦рак полового члена     ¦хирургическое  ¦резекция полового члена с     ¦          ¦

¦     ¦                      ¦                  ¦I-IV стадии            ¦лечение        ¦пластикой                     ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C61       ¦рак предстательной     ¦хирургическое  ¦радикальная простатэктомия    ¦          ¦

¦     ¦                      ¦                  ¦железы II стадии       ¦лечение        ¦промежностным доступом        ¦          ¦

¦     ¦                      ¦                  ¦(T1c-2bN 0M0), уровень ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦ПСА менее 10 нг/мл,    ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦сумма баллов по        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦Глисону менее 7        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  +-----------------------+               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦рак предстательной     ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦железы II стадии,      ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦T1b-T2cN xMo           ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  +-----------------------+               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦рак предстательной     ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦железы II-III стадии   ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦(T1c-2bN 0M0) с        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦высоким риском         ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦регионарного           ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦метастазирования       ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  +-----------------------+               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦локализованный рак     ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦предстательной железы  ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦I-II стадии, T1-2cN 0M0¦               ¦                              ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C64       ¦рак единственной почки ¦хирургическое  ¦резекция почечной лоханки с   ¦          ¦

¦     ¦                      ¦                  ¦с инвазией в лоханку   ¦лечение        ¦пиелопластикой                ¦          ¦

¦     ¦                      ¦                  ¦почки                  ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦злокачественные        ¦хирургическое  ¦радикальная нефрэктомия с     ¦          ¦

¦     ¦                      ¦                  ¦новообразования почки  ¦лечение        ¦расширенной забрюшинной       ¦          ¦

¦     ¦                      ¦                  ¦III-IV стадии          ¦               ¦лимфаденэктомией              ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦рак почки I-III стадии ¦хирургическое  ¦радикальная нефрэктомия с     ¦          ¦

¦     ¦                      ¦                  ¦T1a-T3aN xMo           ¦лечение        ¦резекцией соседних органов    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦удаление рецидивной опухоли   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦почки с расширенной           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденэктомией              ¦          ¦

¦     ¦                      ¦                  ¦                       +---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦удаление рецидивной опухоли   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦почки с резекцией соседних    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦органов                       ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C67       ¦рак мочевого пузыря    ¦хирургическое  ¦цистпростатвезикулэктомия с   ¦          ¦

¦     ¦                      ¦                  ¦I-IV стадии            ¦лечение        ¦пластикой мочевого резервуара ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦сегментом тонкой кишки        ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦передняя экзентерация таза    ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C74       ¦рак надпочечника I-III ¦хирургическое  ¦лапароскопическое удаление    ¦          ¦

¦     ¦                      ¦                  ¦стадии (T1a-T3aN xMo)  ¦лечение        ¦рецидивной опухоли            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦надпочечника с расширенной    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лимфаденэктомией              ¦          ¦

¦     ¦                      ¦                  ¦                       +---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦удаление рецидивной опухоли   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦надпочечника с резекцией      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦соседних органов              ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦рак надпочечника       ¦хирургическое  ¦лапароскопическая расширенная ¦          ¦

¦     ¦                      ¦                  ¦III-IV стадии          ¦лечение        ¦адреналэктомия или            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦адреналэктомия с резекцией    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦соседних органов              ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦ 19  ¦Комбинированное       ¦  C00, C01, C02,  ¦злокачественные        ¦комбинированное¦внутриартериальная или        ¦          ¦

¦     ¦лечение               ¦ C03, C04, C05.0, ¦новообразования головы ¦лечение        ¦системная предоперационная    ¦          ¦

¦     ¦злокачественных       ¦  C05, C06, C07,  ¦и шеи T3-4, рецидив    ¦               ¦полихимиотерапия с            ¦          ¦

¦     ¦новообразований,      ¦  C08, C09, C10,  ¦                       ¦               ¦последующей операцией в       ¦          ¦

¦     ¦сочетающее обширные   ¦  C11, C12, C13,  ¦                       ¦               ¦течение одной госпитализации  ¦          ¦

¦     ¦хирургические         ¦ C14, C15.0, C30, ¦                       ¦               ¦                              ¦          ¦

¦     ¦вмешательства и       ¦  C31, C32, C33,  ¦                       ¦               ¦                              ¦          ¦

¦     ¦лекарственное         ¦ C43, C44, C49.0, ¦                       ¦               ¦                              ¦          ¦

¦     ¦противоопухолевое     ¦     C69, C73     ¦                       ¦               ¦                              ¦          ¦

¦     ¦лечение, требующее    ¦                  ¦                       ¦               ¦                              ¦          ¦

¦     ¦интенсивной           ¦                  ¦                       ¦               ¦                              ¦          ¦

¦     ¦поддерживающей и      ¦                  ¦                       ¦               ¦                              ¦          ¦

¦     ¦коррегирующей терапии ¦                  ¦                       ¦               ¦                              ¦          ¦

¦     ¦                      +------------------+-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦        C16       ¦местнораспространенный ¦комбинированное¦хирургическое лечение с       ¦          ¦

¦     ¦                      ¦                  ¦рак желудка (T2N 2M0,  ¦лечение        ¦последующим курсом            ¦          ¦

¦     ¦                      ¦                  ¦T3N 1M0, T4N 0M0, T3N  ¦               ¦химиотерапии в течение одной  ¦          ¦

¦     ¦                      ¦                  ¦2M0, T4N 1-3M0-1)      ¦               ¦госпитализации                ¦          ¦

¦     ¦                      ¦                  ¦после операций в       ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦объеме R0              ¦               ¦                              ¦          ¦

¦     ¦                      +------------------+-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦   C18, C19, C20  ¦местнораспространенный ¦комбинированное¦хирургическое лечение с       ¦          ¦

¦     ¦                      ¦                  ¦колоректальный рак     ¦лечение        ¦последующим курсом            ¦          ¦

¦     ¦                      ¦                  ¦T1-2N 1M0, T3- 4N 1M0, ¦               ¦химиотерапии в течение одной  ¦          ¦

¦     ¦                      ¦                  ¦T1-4N 2M0              ¦               ¦госпитализации                ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦метастатический        ¦комбинированное¦предоперационная химиотерапия ¦          ¦

¦     ¦                      ¦                  ¦колоректальный рак,    ¦лечение        ¦с применением таргетных       ¦          ¦

¦     ¦                      ¦                  ¦предполагающий         ¦               ¦лекарственных препаратов      ¦          ¦

¦     ¦                      ¦                  ¦использование на одном ¦               ¦после проведения генетических ¦          ¦

¦     ¦                      ¦                  ¦из этапов лечения      ¦               ¦исследований (определение     ¦          ¦

¦     ¦                      ¦                  ¦хирургического метода  ¦               ¦мутаций) с последующим        ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургическим лечением в      ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦течение одной госпитализации  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургическое лечение с       ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦последующим курсом            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапии с применением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦таргетных лекарственных       ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦препаратов после проведения   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦генетических исследований     ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦(определение мутаций) в       ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦течение одной госпитализации  ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C34       ¦местнораспространенный ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦рак легкого T3N 1M0,   ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦T1-3N 2M0, T4N 0-2M0,  ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦T1-4N 3M0              ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦    C40, C41.2,   ¦первичные              ¦комбинированное¦внутриартериальная            ¦          ¦

¦     ¦                      ¦   C41.3, C41.4,  ¦злокачественные        ¦лечение        ¦химиотерапия с последующим    ¦          ¦

¦     ¦                      ¦   C41.8, C41.9   ¦новообразования костей ¦               ¦хирургическим вмешательством  ¦          ¦

¦     ¦                      ¦                  ¦и суставных хрящей     ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦туловища и конечностей ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦II b-IVa,b стадии.     ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦Первичные              ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦злокачественные        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦новообразования мягких ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦тканей туловища и      ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦конечностей II a-b,    ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦III, IV стадии         ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C48       ¦местнораспространенные ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦и метастатические      ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦формы первичных и      ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦рецидивных неорганных  ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦опухолей забрюшинного  ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  ¦пространства           ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦местнораспространенные ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦формы опухолей брюшной ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦стенки                 ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C50       ¦первичный рак молочной ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦железы T1-3N 0-1M0     ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦первичный рак молочной ¦комбинированное¦предоперационная              ¦          ¦

¦     ¦                      ¦                  ¦железы T1N 2-3M0,      ¦лечение        ¦химиотерапия, в том числе в   ¦          ¦

¦     ¦                      ¦                  ¦T2-3N 1-3M0            ¦               ¦сочетании с таргетными        ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лекарственными препаратами, с ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦проведением хирургического    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦вмешательства в течение одной ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦госпитализации                ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦метастатический и      ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦рецидивный рак         ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦молочной железы,       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦предполагающий         ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦использование на одном ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  ¦из этапов лечения      ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦хирургического метода  ¦               ¦                              ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C53       ¦местнораспространенные ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦формы рака шейки матки ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C54       ¦злокачественные        ¦комбинированное¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦новообразования        ¦лечение        ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦эндометрия II-III      ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦стадии                 ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C56       ¦злокачественные        ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦новообразования        ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦яичников I-IV стадии   ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦рецидивы рака яичников ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦                       ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C62       ¦местнораспространенный,¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦метастатический и      ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦рецидивный рак яичка   ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦рак яичка I-III стадии ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦T1-4N 1-3M0-1          ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C64       ¦рак почки IV стадии    ¦комбинированное¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦T3b-3c4, N 0-1M1       ¦лечение        ¦лекарственная терапия с       ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦проведением хирургического    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦вмешательства в течение одной ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦госпитализации                ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦   C65, C66, C67  ¦местнораспространенный ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦уротелиальный рак      ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦T3-4N 0M0 при          ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦планировании           ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦органосохраняющей      ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  ¦операции               ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  +-----------------------+---------------+------------------------------+          ¦

¦     ¦                      ¦                  ¦местнораспространенный ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦уротелиальный рак      ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦T1-4N 1-3M0            ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦  C00, C01, C02,  ¦опухоли головы и шеи у ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦  C03, C04, C05,  ¦детей: остеосаркома,   ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦  C09, C10, C11,  ¦опухоли семейства      ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦ C30, C31, C41.0, ¦саркомы Юинга, саркомы ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦   C41.1, C49.0,  ¦мягких тканей,         ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦   C69.2, C69.4,  ¦хондросаркома,         ¦               ¦                              ¦          ¦

¦     ¦                      ¦       C69.6      ¦злокачественная        ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦фиброзная              ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦гистиоцитома,          ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦ретинобластома         ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦комплексное лечение с         ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦применением высокотоксичных   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦противоопухолевых             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лекарственных препаратов,     ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦включая таргетные             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лекарственные препараты, при  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦развитии выраженных           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦токсических реакций с         ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦применением сопроводительной  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦терапии, требующей            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦постоянного мониторирования в ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦стационарных условиях         ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦        C71       ¦опухоли центральной    ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦                  ¦нервной системы у детей¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦комплексное лечение с         ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦применением высокотоксичных   ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦противоопухолевых             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лекарственных препаратов,     ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦включая таргетные             ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦лекарственные препараты, при  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦развитии выраженных           ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦токсических реакций с         ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦применением сопроводительной  ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦терапии, требующей            ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦постоянного мониторирования в ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               ¦стационарных условиях         ¦          ¦

+-----+----------------------+------------------+-----------------------+---------------+------------------------------+----------+

¦     ¦                      ¦  C22, C34, C38,  ¦злокачественные        ¦комбинированное¦предоперационная или          ¦          ¦

¦     ¦                      ¦    C48.0, C52,   ¦новообразования        ¦лечение        ¦послеоперационная             ¦          ¦

¦     ¦                      ¦ C53.9, C56, C61, ¦торако-абдоминальной   ¦               ¦химиотерапия с проведением    ¦          ¦

¦     ¦                      ¦ C62, C64, C67.8, ¦локализации у детей    ¦               ¦хирургического вмешательства  ¦          ¦

¦     ¦                      ¦        C74       ¦(опухоли средостения,  ¦               ¦в течение одной госпитализации¦          ¦

¦     ¦                      ¦                  ¦опухоли надпочечника,  ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦опухоли печени, яичка, ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦яичников, неорганные   ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦забрюшинные опухоли,   ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦опухоли почки,         ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦мочевыводящей системы  ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦и другие). Программное ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦лечение                ¦               ¦                              ¦          ¦

¦     ¦                      ¦                  ¦                       ¦               +------------------------------+          ¦